期刊文献+

子宫内膜癌保留生育功能多学科诊疗中国专家共识 被引量:3

Chinese expert consensus on multiple disciplinary treatment in endometrial cancer desiring fertility preserving treatment
原文传递
导出
摘要 子宫内膜癌发病率不断上升,尤其在中国呈明显年轻化趋势。许多年轻子宫内膜癌患者有迫切生育要求,这使子宫内膜癌保留生育功能治疗成为肿瘤生殖学领域的研究热点。子宫内膜癌保留生育功能治疗涉及妇科肿瘤、生殖内分泌、影像、病理、产科、内分泌等多个学科,目前尚缺乏成熟的子宫内膜癌保留生育功能多学科诊疗规范。本专家共识旨在通过建立规范的子宫内膜癌保留生育功能诊治多学科体系,达到提升子宫内膜癌保留生育功能治疗的有效性和安全性的目的。 The incidence of endometrial cancer is increasing,with the trend of affecting more young women in China.The fact that a large part of young women has not finished childbearing when diagnosed as endometrial cancer makes fertility preserving treatment of endometrial cancer a new challenge in the field of gynecologic oncology and reproductive medicine.Fertility preserving treatment of endometrial cancer involves multiple disciplines including gynecologic oncology,reproductive medicine,radiology,pathology,metabolism and obstetrics,etc.There is no guidance at present for multiple disciplinary treatment(MDT)in fertility preserving treatment of endometrial cancer.The consensus aimed to establish the MDT system and help improve the efficacy and safety in fertility preserving treatment of endometrial cancer.
作者 子宫内膜癌保留生育功能多学科诊疗中国专家共识编写组 陈晓军 罗雪珍 王超 王懿琴 马凤华 张宏伟 孙莉 余敏 彭婷 张鹏 程亚丽 王建六 臧荣余 Chinese Expert Consensus Compilation Group for Multiple Disciplinary Treatment in Endometrial Cancer Desiring Fertility Preserving Treatment;Chen Xiaojun
出处 《中华生殖与避孕杂志》 CAS CSCD 北大核心 2023年第4期346-356,共11页 Chinese Journal of Reproduction and Contraception
基金 国家重点研发计划(2019YFC1005200) 申康临床科技创新项目(SHDC22021219)。
关键词 子宫内膜肿瘤 保留生育能力 多学科诊疗 Endometrial neoplasms Fertility preservation Multiple disciplinary treatment
  • 相关文献

参考文献7

二级参考文献68

  • 1Denny L,Quinn M, Hacker N. FIGO Cancer Report 2012 [ J]. Int J Gynaecol Obstet, 2012,119 ( Suppl 2 ) : $89.
  • 2Greer BE, Koh WJ, Abu-Rustum N, et al. Uterine Neoplasms. Clinical Practice Guidelines in Oncology[ J]. J Natl Compr Canc Netw, 2009,7 ( 5 ) :498-531.
  • 3Zivanovic O, Carter J, Kauff ND, et al. A review of the challen- ges faced in the conservative treatment of young women with en- dometrial carcinoma and risk of ovarian cancer[ J]. Gynecol On- col, 2009,115(3) :504-509.
  • 4Sorosky JI. Endometrial cancer[ J]. Obstet Gynecol, 2008,111 (2 Pt 1 ) :436-447.
  • 5Mao Y, Wan X, Chen , et al. Outcomes of conservative thera- py for young women with early endometrial adenocarcinoma [ J ]. Fertil Steril, 2010,93 ( 1 ) :283-285.
  • 6Kim MK, Yoon BS, Park H, et al. Conservative treatment with medroxyprogesterone acetate plus levonorgestrel intrauterine sys- tem for early-stae endometrial cancer in youn women: pilotstudy[J]. Int J Gynecol Cancer, 2011,21 (4) :673-677.
  • 7Yamazawa K, Hirai M, Fujito A, et al. Fertility-preserving treat- ment with progestin, and pathological criteria to predict respon- ses, in young women with endometrial cancer[ J]. Hum Reprod, 2007,22 (7) : 1953-1958.
  • 8Frumovitz M, Gershenson DM. Fertility-sparing therapy for young women with endometrial cancer [ J ]. Expert Rev Anticancer T- her, 2006,6( 1 ) :27-32.
  • 9Benshushan A. Endometrial adenocarcinoma in young patients: evaluation and fertility-preserving treatment [ J ]. Eur J Obstet Gynecol Reprod Biol, 2004,117(2) :132-137.
  • 10Yang YC, Wu CC, Chen CP, et al. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer [ J]. Gynecol Oncol, 2005,99(2) :287-295.

共引文献129

同被引文献11

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部